Subscribe

Image – Interventional flashlight

DOI: 10.4244/EIJ-D-20-00158

Direct visualisation of the BASILICA technique post TAVR to enhance coronary flow

Jorge D. Zhingre Sanchez1,2, BS; Tinen L. Iles2, PhD; Danny Dvir3, MD; Paul A. Iaizzo2, PhD, FHRS

Figure 1. Still images of BASILICA technique procedures recorded from aortic (A,C,E,G) and left ventricular (B,D,F,H) views.

Obstruction of blood flow to the coronary arteries during transcatheter aortic valve replacement (TAVR) is a potentially fatal complication that occurs in ~2.3% of valve-in-valve procedures. Many patients identified at risk of coronary obstruction remain too high a risk for open heart surgery and their treatment is limited to palliative care. In May 2017, a collaboration between the National Institutes of Health (NIH) and the University of Washington developed an electrosurgery catheter-based technique, to slice the leaflets of a failing valve or prosthesis intentionally, so as to increase coronary flow through the displaced leaflets1,2. Bioprosthetic or native Aortic Scallop Intentional Laceration to prevent Iatrogenic Coronary Artery obstruction (BASILICA) has demonstrated feasibility and effectiveness in investigational trials3.

For over two decades, the Visible Heart® Laboratories have utilised a large mammalian ex vivo beating heart preparation to design, test, and develop novel cardiac devices and therapeutic techniques4. Uniquely, we visualised the BASILICA procedure performed by D. Dvir on an implanted 29 mm Evolut™ R (Medtronic, Minneapolis, MN, USA) during TAVR in a reanimated swine heart. Still images of each procedural step were recorded from aortic (Figure 1A, Figure 1C, Figure 1E, Figure 1G) and left ventricular (Figure 1B, Figure 1D, Figure 1F, Figure 1H) views. An electrified guidewire (Astato XS20; Asahi Intecc, Tustin, CA, USA) perforated through the left cusp of the Evolut R and was directed into the open snare positioned in the left ventricular outflow tract (Figure 1A, Figure 1B). The guidewire distal end was captured using snare (ev3 Amplatz Goose Neck™; Medtronic) retrieval (Figure 1C, Figure 1D). The pre-prepared mid-shaft of the guidewire and coronary guide catheter assembly (6 Fr Launcher®; Medtronic) were positioned at the leaflet for laceration (Figure 1E, Figure 1F). An electrosurgical generator (Force FX™; Medtronic) supplied radiofrequency energy of 70W for guidewire perforation and 150W during leaflet laceration. Resulting laceration of the Evolut R prosthesis left cusp allowed the leaflet to splay open (Figure 1G, Figure 1H).

The Visible Heart video of the entire BASILICA procedure and the intentional lacerations within the implanted Evolut R left and right coronary leaflets are provided (Moving image 1). Direct videoscopic visualisation provides educational material for interventional cardiologists aiming to learn and perfect this critical procedure, and industry professionals developing tools to facilitate its clinical application.

Acknowledgements

We wish to acknowledge Dr Michael Bateman and Visible Heart Laboratories staff for their contributions.

Conflict of interest statement

P.A. Iaizzo has a research contract with Medtronic and has received grants from the Institute for Engineering in Medicine (University of Minnesota). D. Dvir is a consultant for Medtronic and Edwards Lifesciences. T. Iles reports other from Medtronic, and grants from the Institute for Engineering in Medicine (University of Minnesota), during the conduct of the study. J. Zhingre Sanchez reports other from Medtronic, and grants from the Institute for Engineering in Medicine (University of Minnesota), during the conduct of the study.

Supplementary data

To read the full content of this article, please download the PDF.

Moving image 1. Double-leaflet BASILICA procedure performed in vitro on an Evolut R prosthesis deployed in a reanimated swine heart using Visible Heart methodologies.

Volume 16 Number 8
Oct 23, 2020
Volume 16 Number 8
View full issue


Key metrics

Suggested by Cory

Editorial

10.4244/EIJ-E-23-00026 Aug 7, 2023
Orthotopic stenting after BASILICA – an indicator of procedural success
Rogers T and Bruce C
free

10.4244/EIJV16I8A114 Oct 23, 2020
Consolidating the BASILICA technique in TAVI patients at risk of coronary obstruction
Rodés-Cabau J and Ribeiro H
free

Clinical research

10.4244/EIJ-D-22-00960 Aug 7, 2023
Procedural and one-year outcomes of the BASILICA technique in Europe: the multicentre EURO-BASILICA registry
Abdel-Wahab M et al
free
Trending articles
56.1

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
56.1

Original Research

10.4244/EIJ-D-25-00331 Jul 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
48.8

State-of-the-Art

10.4244/EIJ-D-24-00992 Sep 15, 2025
Antithrombotic therapy in complex percutaneous coronary intervention
Castiello D et al
free
28.25

Clinical research

10.4244/EIJ-D-19-01006 Aug 7, 2020
Coronary collaterals and myocardial viability in patients with chronic total occlusions
Schumacher S et al
free
Chat with Cory
Hello , I'm Cory and I will do my best to answer your questions about this article. Please remember that this is an experimental feature, and that I'm still learning.
What percentage of valve-in-valve TAVR procedures experience coronary obstruction?
How was the BASILICA technique developed and tested?
What type of patients was the technique aimed to help?
What viewpoints does the video provided show of the BASILICA procedure?
X

PCR
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved